Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suning Chen

Showing results (251-260 of 368) with videos related to

Pageof 37
Sort By:
Molecular Pharmacology|January 12, 2011
The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidenceXinliang Mao, Tingjun Hou, Biyin Cao, et al.
Annals of Hematology|June 10, 2023
The efficacy of first salvage therapy determines the outcomes of adult patients with type 1 primary refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationZhiyou Yu, Yao Yao, Yanming Zhang, et al.
Leukemia & Lymphoma|December 18, 2019
Combining gene variants with clinical characteristics improves outcome prediction in Chinese patients with myelodysplastic syndromesYan Yu, Tongtong Zhang, Xiebing Bao, et al.
Oncotarget|December 20, 2017
High Tim-3 expression on AML blasts could enhance chemotherapy sensitivityLiangjing Xu, Jinge Xu, Shoubao Ma, et al.
Frontiers in Oncology|July 2, 2021
G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical ModelsLixia Zhou, Tenghua Yu, Fei Yang, et al.
Hematology (Amsterdam, Netherlands)|May 16, 2023
Outcomes of adult patients with type 1 primary refractory acute myeloid leukemia: a single center experienceZhiyou Yu, Yao Yao, Yanming Zhang, et al.
Plos One|October 14, 2025
HLF gene is a poor prognostic factor in acute myeloid leukemia patients with FLT3-ITD/NPM1 mutations undergoing hematopoietic transplantationXiaoyu Xu, Xinxin Ge, Airui Jiang, et al.
Frontiers in Oncology|February 8, 2021
Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of LiteratureXuewei Li, Nana Ping, Yong Wang, et al.
Blood Cancer Journal|June 20, 2018
Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML allianceJingru Zhang, Yingqiao Wang, Jianxiang Wang, et al.
Cancer & Metabolism|December 6, 2022
Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancerYao Shen, Pan Zhao, Kewei Dong, et al.
Pageof 37

Showing results (251-260 of 368) with videos related to

Sort By:
Pageof 37
Molecular Pharmacology|January 12, 2011
The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidenceXinliang Mao, Tingjun Hou, Biyin Cao, et al.
Annals of Hematology|June 10, 2023
The efficacy of first salvage therapy determines the outcomes of adult patients with type 1 primary refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationZhiyou Yu, Yao Yao, Yanming Zhang, et al.
Leukemia & Lymphoma|December 18, 2019
Combining gene variants with clinical characteristics improves outcome prediction in Chinese patients with myelodysplastic syndromesYan Yu, Tongtong Zhang, Xiebing Bao, et al.
Oncotarget|December 20, 2017
High Tim-3 expression on AML blasts could enhance chemotherapy sensitivityLiangjing Xu, Jinge Xu, Shoubao Ma, et al.
Frontiers in Oncology|July 2, 2021
G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical ModelsLixia Zhou, Tenghua Yu, Fei Yang, et al.
Hematology (Amsterdam, Netherlands)|May 16, 2023
Outcomes of adult patients with type 1 primary refractory acute myeloid leukemia: a single center experienceZhiyou Yu, Yao Yao, Yanming Zhang, et al.
Plos One|October 14, 2025
HLF gene is a poor prognostic factor in acute myeloid leukemia patients with FLT3-ITD/NPM1 mutations undergoing hematopoietic transplantationXiaoyu Xu, Xinxin Ge, Airui Jiang, et al.
Frontiers in Oncology|February 8, 2021
Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of LiteratureXuewei Li, Nana Ping, Yong Wang, et al.
Blood Cancer Journal|June 20, 2018
Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML allianceJingru Zhang, Yingqiao Wang, Jianxiang Wang, et al.
Cancer & Metabolism|December 6, 2022
Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancerYao Shen, Pan Zhao, Kewei Dong, et al.
Pageof 37